GLYCOPROTEIN OF HUMAN ORIGIN, PHYSIOLOGICALLY ACTIVE FACTOR COMPRISING THE SAME, AND PHARMACEUTICAL PREPARATION CONTAINING THE SAME AS ACTIVE INGREDIENT

• 1. 植物来源的活性成分或其合成类似物或包含活性成分的植物来源的提取物及卵磷脂的制剂 [P] . 中国专利： CN103037881B . 2016.12.28
• 2. 植物来源的活性成分或其合成类似物或包含活性成分的植物来源的提取物及卵磷脂的新制剂 [P] . 中国专利： CN103037881A . 2013-04-10
• 3. Glycoprotein of human origin; Physiologically active factor comprising the same, and pharmaceutical preparation containing the same as active ingredient. [P] . ES2075199T3 . 1995-10-01

  机译： 人源糖蛋白;包含其的生理活性因子，以及包含其作为活性成分的药物制剂。

• 4. GLYCOPROTEIN OF HUMAN ORIGIN, PHYSIOLOGICALLY ACTIVE FACTOR COMPRISING THE SAME, AND PHARMACEUTICAL PREPARATION CONTAINING THE SAME AS ACTIVE INGREDIENT [P] . 欧洲知识产权局专利： EP0462277B1 . 1995-06-07

  机译： 人体来源的糖蛋白，包含相同成分的生理活性因子以及包含相同成分的药物制剂

• 5. GLYCOPROTEIN OF HUMAN ORIGIN, PHYSIOLOGICALLY ACTIVE FACTOR COMPRISING THE SAME, AND PHARMACEUTICAL PREPARATION CONTAINING THE SAME AS ACTIVE INGREDIENT [P] . AU629314B2 . 1992-10-01

  机译： 人体来源的糖蛋白，包含相同成分的生理活性因子以及包含相同成分的药物制剂

• 1. Simultaneous and Trace Level Quantification of Five Potential Genotoxic Impurities in Ranolazine Active Pharmaceutical Ingredient Using LC-MS/MS [J] . Kartheek Srinivas Chidella, Vijaya Bharathi Dasari, Jayashree Anireddy 美国分析化学（英文） . 2021,第001期
• 2. Development of a rapid GC-FID method to simultaneously determine triethylamine,diisopropylamine,and 1,1,3,3-tetramethylguanidine residues in an active pharmaceutical ingredient [J] . Minshan Shou, Haixiao Qiu 药物分析学报（英文） . 2021,第002期
• 3. Multiple Emulsions Able to Be Used for Oral Administration of Active Pharmaceutical Ingredients: Physico-Chemical Parameters Study of Different Phases [J] . Louis Augustin Diaga Diouf, Alphonse Rodrigue Djiboune, Mamadou Soumboundou, 现代物理（英文） . 2020,第010期
• 4. Nanoparticle preparation of active pharmaceutical ingredients (APIs) by emulsion solvent diffusion method with cyclodextrins [C] . Liu Kexin, Li Keyun Asian Particle Technology Symposium . 2007
• 5. Improved Characterization of Pure and Formulated Active Pharmaceutical Ingredients by Fast Magic Angle Spinning Solid-State NMR Spectroscopy [D] . Wijesekara, Anuradha V. 2020
• 6. Potential ecological footprints of active pharmaceutical ingredients: an examination of risk factors in low- middle- and high-income countries [O] . Rai S. Kookana, Mike Williams, Alistair B. A. Boxall, 2014
• 7. DEVELOPMENT OF TECHNOLOGIES FOR OBTAINING ACTIVE PHARMACEUTICAL INGREDIENTS, MEDICINAL AND DIAGNOSTIC PREPARATIONS BASED ON LIPIDS IN UKRAINE [O] . Yuriy Krasnopolsky 2020

• 1. Simultaneous Determination of N-Acetyl Cysteine and Taurine by HPTLC Method in Active Pharmaceutical Ingredient and Pharmaceutical Dosage Form [J] . A. R. Magesh ,Magharla Dasaratha Dhanaraju . 美国分析化学（英文） . 2017,第11期
• 2. Analysis of the Current Situation of Active Pharmaceutical Ingredient (API) Export in China [J] . Kong Deqiang1 ,Dong Li1 . 亚洲社会药学 . 2019,第003期
• 3. ICP-OES法直接测定钬铒富集物中包含主量和微量成分的7个稀土元素含量 [C] . 梁斌 ,范素珍 . 第十三届全国稀土化学分析学术研讨会 . 2011
• 4. 2m(2l)1设计包含纯净的两因子交互作用成分的条件 [A] . 单晓晨 . 2012